SYL1001

· Sylentis, S.A.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for SYL1001, covering 2012-07-17 to 2019-02-15. Get the full timeline:

Most recent: Clinical Trial Update: HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED) [Phase 3]